MedDataX Logo

Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life

NCT ID: NCT01100073

Last Updated: 2014-04-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1703 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will compare the effect of pramipexole on different types of tremor and particularly kinetic tremor in early and advanced Parkinson's disease patients and will evaluate the course of tremor measured with spiralometry under pramipexole treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice

NCT01061567

Parkinson's Disease
COMPLETED

First Presentation of Parkinson Disease Patients to Neurologist

NCT00802178

Parkinson Disease
COMPLETED

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

NCT00601523

Parkinson Disease
COMPLETED PHASE3

Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

NCT02177357

Parkinson Disease
COMPLETED PHASE3

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

NCT00096720

Parkinson Disease Parkinsonian Syndrome
COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Parkinson's disease

Early and advanced Parkinson's disease patients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Idiopathic Parkinson's disease with or without fluctuations
2. Indication for treatment with pramipexole (Mirapexin®)
3. Presence of at least mild tremor symptoms (as judged by the treating physician)

Exclusion Criteria

1. Any contraindications according to the Summary of Product Characteristics (SPC): hypersensitivity to pramipexole or to any of the excipients.
2. Ongoing treatment with pramipexole (Mirapexin®)
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Boehringer Ingelheim

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site 5

Keila, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 4

Kohtla-Järve, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 6

Rakvere, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 1

Tallinn, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 2

Tallinn, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 3

Tallinn, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 7

Tartu, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 8

Valga, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 9

Kuldīga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 12

Liepāja, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 13

Liepāja, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 14

Liepāja, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 15

Liepāja, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 10

Limbaži, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 11

Limbaži, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 16

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 17

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 18

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 19

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 20

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 21

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 22

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 23

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 24

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 25

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 26

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 27

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 28

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 29

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 30

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 31

Riga, , Latvia

Site Status

Boehringer Ingelheim Investigational Site 32

Aiud, , Romania

Site Status

Boehringer Ingelheim Investigational Site 33

Arges, , Romania

Site Status

Boehringer Ingelheim Investigational Site 34

Arges, , Romania

Site Status

Boehringer Ingelheim Investigational Site 35

Arges, , Romania

Site Status

Boehringer Ingelheim Investigational Site 36

Arges, , Romania

Site Status

Boehringer Ingelheim Investigational Site 37

Arges, , Romania

Site Status

Boehringer Ingelheim Investigational Site 38

Arges, , Romania

Site Status

Boehringer Ingelheim Investigational Site 39

Arges, , Romania

Site Status

Boehringer Ingelheim Investigational Site 40

Bacau, , Romania

Site Status

Boehringer Ingelheim Investigational Site 41

Bacau, , Romania

Site Status

Boehringer Ingelheim Investigational Site 42

Bistriţa, , Romania

Site Status

Boehringer Ingelheim Investigational Site 43

Botoșani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 44

Botoșani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 47

Brasov, , Romania

Site Status

Boehringer Ingelheim Investigational Site 48

Brasov, , Romania

Site Status

Boehringer Ingelheim Investigational Site 45

Brăila, , Romania

Site Status

Boehringer Ingelheim Investigational Site 46

Brăila, , Romania

Site Status

Boehringer Ingelheim Investigational Site 49

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 50

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 51

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 52

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 53

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 54

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 55

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 56

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 57

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 58

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 59

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 60

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 61

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 62

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 63

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 64

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 65

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 66

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 67

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 68

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 69

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 70

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 71

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 72

Buzău, , Romania

Site Status

Boehringer Ingelheim Investigational Site 73

Buzău, , Romania

Site Status

Boehringer Ingelheim Investigational Site 74

Caracal, , Romania

Site Status

Boehringer Ingelheim Investigational Site 75

Cluj-Napoca, , Romania

Site Status

Boehringer Ingelheim Investigational Site 76

Cluj-Napoca, , Romania

Site Status

Boehringer Ingelheim Investigational Site 77

Cluj-Napoca, , Romania

Site Status

Boehringer Ingelheim Investigational Site 78

Cluj-Napoca, , Romania

Site Status

Boehringer Ingelheim Investigational Site 79

Cluj-Napoca, , Romania

Site Status

Boehringer Ingelheim Investigational Site 80

Cluj-Napoca, , Romania

Site Status

Boehringer Ingelheim Investigational Site 81

Constanța, , Romania

Site Status

Boehringer Ingelheim Investigational Site 82

Constanța, , Romania

Site Status

Boehringer Ingelheim Investigational Site 83

Craiova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 84

Craiova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 85

Craiova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 86

Craiova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 87

Deva, , Romania

Site Status

Boehringer Ingelheim Investigational Site 88

Deva, , Romania

Site Status

Boehringer Ingelheim Investigational Site 89

Focşani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 90

Focşani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 91

Galati, , Romania

Site Status

Boehringer Ingelheim Investigational Site 92

Galati, , Romania

Site Status

Boehringer Ingelheim Investigational Site 93

Hunedoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 94

Hunedoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 95

Iași, , Romania

Site Status

Boehringer Ingelheim Investigational Site 96

Iași, , Romania

Site Status

Boehringer Ingelheim Investigational Site 97

Iași, , Romania

Site Status

Boehringer Ingelheim Investigational Site 98

Iași, , Romania

Site Status

Boehringer Ingelheim Investigational Site 99

Lugoj, , Romania

Site Status

Boehringer Ingelheim Investigational Site 100

Maramures, , Romania

Site Status

Boehringer Ingelheim Investigational Site 101

Orăştie, , Romania

Site Status

Boehringer Ingelheim Investigational Site 102

Paşcani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 103

Paşcani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 104

Petroşani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 105

Piatra Neamţ, , Romania

Site Status

Boehringer Ingelheim Investigational Site 106

Prahova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 107

Prahova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 108

Prahova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 109

Radauti, , Romania

Site Status

Boehringer Ingelheim Investigational Site 110

Reşiţa, , Romania

Site Status

Boehringer Ingelheim Investigational Site 111

Satu Mare, , Romania

Site Status

Boehringer Ingelheim Investigational Site 112

Sibiu, , Romania

Site Status

Boehringer Ingelheim Investigational Site 113

Sibiu, , Romania

Site Status

Boehringer Ingelheim Investigational Site 114

Slatina, , Romania

Site Status

Boehringer Ingelheim Investigational Site 115

Suceava, , Romania

Site Status

Boehringer Ingelheim Investigational Site 116

Suceava, , Romania

Site Status

Boehringer Ingelheim Investigational Site 117

Teleorman, , Romania

Site Status

Boehringer Ingelheim Investigational Site 118

Tg. Mures, , Romania

Site Status

Boehringer Ingelheim Investigational Site 119

Timișoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 120

Timișoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 121

Timișoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 122

Timișoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 123

Tulcea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 124

Tulcea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 131

Krasnodar, , Russia

Site Status

Boehringer Ingelheim Investigational Site 130

Krasnoyarsk, , Russia

Site Status

Boehringer Ingelheim Investigational Site 125

Moscow, , Russia

Site Status

Boehringer Ingelheim Investigational Site 126

Moscow, , Russia

Site Status

Boehringer Ingelheim Investigational Site 127

Moscow, , Russia

Site Status

Boehringer Ingelheim Investigational Site 128

Novosibirsk, , Russia

Site Status

Boehringer Ingelheim Investigational Site 132

Saint Petersburg, , Russia

Site Status

Boehringer Ingelheim Investigational Site 133

Saint Petersburg, , Russia

Site Status

Boehringer Ingelheim Investigational Site 134

Saint Petersburg, , Russia

Site Status

Boehringer Ingelheim Investigational Site 129

Tomsk, , Russia

Site Status

Boehringer Ingelheim Investigational Site 135

Belgrade, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 136

Belgrade, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 140

Kragujevac, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 138

Kruševac, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 141

Niš, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 142

Niš, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 137

Novi Sad, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 143

Sombor, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 145

Užice, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 139

Valjevo, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 144

Vranje, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 155

?adca, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 146

Banská Bystrica, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 147

Bardejov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 148

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 149

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 150

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 151

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 152

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 153

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 154

Brezno, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 156

Humenné, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 157

Ilava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 158

Komárno, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 163

Kosice- Saca, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 159

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 160

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 161

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 162

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 164

Krompachy, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 165

Levice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 166

Liptovský Mikulás, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 167

Lučenec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 168

Martin, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 169

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 170

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 171

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 172

Nováky, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 173

Nové Mesto N/ Váhom, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 174

Pezinok, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 175

Pies?any, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 176

Povazská Bystrica, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 177

Prešov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 178

Prešov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 179

Prešov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 180

Revúca, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 181

Rimavská Sobota, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 182

Rožňava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 183

Rožňava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 185

Sereď, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 186

Skalica, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 187

Stropkov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 184

Šaľa, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 188

Šurany, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 189

Trebišov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 190

Tren?in, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 191

Trnava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 192

Trnava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 193

Trstená, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 194

Veľké Kapušany, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 195

Ziar N/Hronom, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 198

Zlaté Moravce, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 199

Zvolen, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 200

Zvolen, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 196

Žilina, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 197

Žilina, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 205

Bled, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 206

Celje, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 201

Ljubljana, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 202

Ljubljana, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 207

Maribor, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 208

Maribor, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 209

Maribor, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 210

Maribor, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 203

Šempeter pri Gorici, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 204

Šempeter pri Gorici, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 212

Kharkiv, , Ukraine

Site Status

Boehringer Ingelheim Investigational Site 211

Kyiv, , Ukraine

Site Status

Boehringer Ingelheim Investigational Site 215

Lviv, , Ukraine

Site Status

Boehringer Ingelheim Investigational Site 214

Ternopil, , Ukraine

Site Status

Boehringer Ingelheim Investigational Site 213

Vinnitsa, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Estonia Latvia Romania Russia Serbia Slovakia Slovenia Ukraine

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

248.657

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease
NCT02373072 COMPLETED PHASE1
A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease
NCT01711866 COMPLETED PHASE4
Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)
NCT00321854 COMPLETED PHASE4
Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms
NCT00297778 COMPLETED PHASE4
A Study to Evaluate in Patients With Parkinsonian Type Disorders
NCT03683225 ACTIVE_NOT_RECRUITING PHASE2
Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
NCT00479401 COMPLETED PHASE3
Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients
NCT00144300 COMPLETED PHASE4
Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease
NCT02233023 COMPLETED PHASE4
Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole
NCT02236728 COMPLETED
Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease
NCT01097421 COMPLETED
a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients
NCT01361009 COMPLETED
Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations
NCT06614153 COMPLETED PHASE2
Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease
NCT01673724 COMPLETED PHASE4
Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations
NCT01634360 TERMINATED PHASE2
Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease
NCT01525641 COMPLETED
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
NCT01096186 COMPLETED PHASE3
Pivotal Study in Advanced Parkinsons Disease Patients
NCT00466167 COMPLETED PHASE3
The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease
NCT00163085 COMPLETED PHASE2
Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment
NCT00651183 COMPLETED
Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease
NCT02248168 COMPLETED
A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period
NCT00560508 COMPLETED PHASE2/PHASE3
A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients
NCT00402233 COMPLETED PHASE4
PF-06669571 In Subjects With Idiopathic Parkinson's Disease
NCT02565628 COMPLETED PHASE1
The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease
NCT01470859 COMPLETED NA
A Phase 3 Study With P2B001 in Subjects With Early Parkinson's
NCT03329508 COMPLETED PHASE3